Compound details
2-(2H-1,3-benzodioxol-5-yl)-7a-hydroxy-3-methyl-4-(prop-2-en-1-yl)-2,3,3a,4,7,7a-hexahydro-1-benzofuran-7-one
| Compound ID | CDAMM00133 |
|---|---|
| Common name | 2-(2H-1,3-benzodioxol-5-yl)-7a-hydroxy-3-methyl-4-(prop-2-en-1-yl)-2,3,3a,4,7,7a-hexahydro-1-benzofuran-7-one | IUPAC name | 2-(1,3-benzodioxol-5-yl)-7a-hydroxy-3-methyl-4-prop-2-enyl-2,3,3a,4-tetrahydro-1-benzofuran-7-one |
| Molecular formula | C19H20O5 |
| Retention time | 36.38 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 329.139 | Theoretical mz | 329.138 |
| Error | 2.3 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.2198 |
| Inchi key | GNVSNCNUCPCVCC-MKJYOJNNNA-N |
|---|---|
| Smiles | CC1C2C(C=CC(=O)C2(OC1C3=CC4=C(C=C3)OCO4)O)CC=C |
| Superclass | Organoheterocyclic compounds |
| Class | Benzodioxoles |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T23499 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P25101 | EDNRA |
| T23499 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P25101 | EDNRA |
| T23499 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | P25101 | EDNRA |
| T92828 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P24530 | EDNRB |
| T92828 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P24530 | EDNRB |